A second Ebola vaccine is to be offered to around 50,000 people in the Democratic Republic of Congo, as part of a major clinical trial.
Author Archives: biocon
by Katsa Georgia, Koufioti Georgia and Kounios Athanassios The health system remains one of the sectors where vast amounts of money are devoted annually on the government budget, as medicine is a constantly evolving and rising science. Hospitals and, by extension, medical and nursing staff concentrate on the management of a vast amount of information-data […]
Nano Algae Solutions AG, a Swiss Holding company, will install a large-scale production plant in Greece for the cultivation and commercial production of microalgae, with initial investment of €7.4 million by 2024 for the production of 60 tons dry powder yearly, and additional €10 million after 2024 to expand its production capacity. Nano Algae Solutions […]
by Zafeiroula Katsara, MSc Student in Bioeconomy: Biotechnology and Law, International Hellenic University CRISPR/Cas 9 technology gives scientists the ability to add, remove or alter specific sequences on the genome in an easier, economically efficient but also more accurate way. This means that CRISPR technology could be a valuable application on an entire new field […]
“The question ought to be reframed from “why do animals engage in same sex behaviour” to “why not?””
Or how I stopped worrying and love the mutations.
A team from the University of Georgia, U.S., reported successfully creating an albino lizard through gene-editing, a first for reptiles.
Scientists are urging government officials to consider helping to develop an international database to share and analyze DNA sequences.
Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.
The country was going to breed a herd of genetically dehorned cows. Then errors in the cows’ DNA cropped up.